MENU
AUPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aurinia Pharmaceuticals (AUPH) Ownership - Who owns Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
14315 118 Avenue
Phone
+1 250 708-4272
Employees
300
Web
https://www.auriniapharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.08B
P/E Ratio
197.25
Total Cash
358.48M
Projected Growth
N/A
Total Debt
79.37M
Revenue
235.13M
Risk (Beta)
1.35
Dividend Yield
N/A
Total Cash/Share
2.62
Total Debt/Equity
N/A
Revenue/Share
1.61 USD as % of share price
Fundamentals
AUPH
Capitalization
1.08B
P/E Ratio
197.25
Risk (Beta)
1.35
Dividend Yield
N/A
Total Cash
358M
Total Cash/Share
2.62
Total Debt
79.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.61%
Revenue
235M
ROE
N/A
Book Value
377M
P/B Ratio
2.86
Cash Flow
N/A
Earnings
0.04
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.19B
Current Ratio
4.57
Current Revenue Per Employee
199556.67
Dividends Per Share - Security
N/A
EBITDA
31.7M
Float
N/A
Float - Current
N/A
Gross Income Margin
90.73
Revenue To Assets
1.05
Shares Held By Institutions
699M
Shares Outstanding - Current
137M
Total Liabilities
173M
Total Volume MTD
N/A
Value
-1
Gain YTD
-12.138
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
14315 118 Avenue
Phone
+1 250 708-4272
Employees
300
Web
https://www.auriniapharma.com